StockData
Amarin Corp PLC logo

Amarin Corp PLC (AMRN) stock

AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.27−0.04 (-0.35%)

Close on Nov 17, 2026Market cap $249.12MP/E –Yield –

Amarin price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Amarin's price to sales ratio was 1.3× on Nov 11, 2026, against 1.5× a year earlier. Over the last 5 years it ranged from 0.8× to 2.4×, with a median of 1.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.3×+0.0
2025Dec 31, 20251.3×+0.5
2024Dec 31, 20240.8×−0.3
2023Dec 29, 20231.1×−0.1
2022Dec 30, 20221.2×−1.0
2021Dec 31, 20212.2×−1.0
2020Dec 31, 20203.2×−17.8
2019Dec 31, 201921.1×+1.0
2018Dec 31, 201820.1×+13.6
2017Dec 29, 20176.5×−0.5
2016Dec 30, 20167.0×+2.2
2015Dec 31, 20154.8×+1.3
2014Dec 31, 20143.6×–

More Amarin figures

See a number that looks wrong?